Ken Griffin Danaher Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $60.6 Million - $71.1 Million	253,300 Added 80.77%	566,900 $158 Million
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $13.8 Million - $15.7 Million	-58,500 Reduced 15.72%	313,600 $78.4 Million
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $6.92 Million - $7.89 Million	-30,800 Reduced 7.64%	372,100 $92.9 Million
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $10.4 Million - $13.1 Million	-56,100 Reduced 12.22%	402,900 $93.2 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $34.9 Million - $39.8 Million	149,900 Added 48.5%	459,000 $114 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $15.3 Million - $17.5 Million	-68,200 Reduced 18.08%	309,100 $74.2 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $14.8 Million - $17.1 Million	-61,600 Reduced 14.04%	377,300 $95.1 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $7.36 Million - $8.61 Million	30,500 Added 7.47%	438,900 $117 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $63.1 Million - $385 Million	-255,400 Reduced 38.48%	408,400 $105 Million

2,507

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.